Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint.

Alawode, Deborah O T; Fox, Nick C; Zetterberg, Henrik; Heslegrave, Amanda J.

Afiliação

Alawode DOT; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom.
Fox NC; UK Dementia Research Institute at UCL, London, United Kingdom.
Zetterberg H; UK Dementia Research Institute at UCL, London, United Kingdom.
Heslegrave AJ; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom.

Front Neurosci ; 16: 837390, 2022.

Article em En | MEDLINE | ID: mdl-35573283

Palavras-chave

amyloid-beta; blood biomarkers; glial fibrillary acidic protein (GFAP); neurodegeneration; neurofilament light (NfL); phosphorylated tau (p-tau); triggering receptor expressed on myeloid cells 2 (TREM2)

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article